Clinical Trial Update: Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous zoledronic acid added to standard therapies in patients with breast cancer and bone metastases. The study status is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Bone Metastases

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Breast Cancer With Bone Metastasis | Phase 3 | Status: TERMINATED